Previously, some researcher confirmed these results and proved phosphorylation level of AKT in SLE patients, which further support the major role of PI3K/Akt/TSC/mTOR signaling pathway in the disease [58, 59]. This evidence concerns the gene MTOR and systemic lupus erythematosus.